Catalyst Wire Dossier Catalyst Wire Dossier

PT008

· Pearl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PT008, covering 2017-05-09 to 2019-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD [Phase 3]

See pricing